Peregrine Pharmaceuticals | Cassa E Equivalenti



Cassa E Equivalenti Cambiamento Data
Agenus USD 3.46M 6.08M 2025-09
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
BioCryst Pharmaceuticals USD 84.08M 3.95M 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Celldex Therapeutics USD 36.04M 12.99M 2025-09
Eli Lilly USD 9.79B 6.42B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Intrexon USD 9.34M 1.77M 2024-06
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
MacroGenics USD 80.13M 50.56M 2025-09
MannKind USD 127.39M 70.39M 2025-09
Merck USD 18.17B 10.16B 2025-09
Minerva Neurosciences USD 12.29M 2.96M 2025-09
Novartis USD 9.56B 2.9B 2025-09
Novavax USD 268.02M 14.28M 2025-09
Repligen USD 748.75M 39.89M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Xencor USD 28.29M 16.15M 2025-09


Peregrine Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.